Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2024
Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomesDanielle L Jones, Laura C Kusinski, Peter Barker, et al.Diabetes Care|April 20, 2026
Insulin Hypersecretion and Increased Ectopic Fat in South Asian American Adolescents and Young Adults Compared With White and African American Peers: The CHARISMA StudyTalia A Hitt, Andrea Kelly, Darko Stefanovski, et al.The Journal of Applied Laboratory Medicine|July 7, 2022
The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating LevelsYanislava Karusheva, Matthew Ratcliff, Alexander Mörseburg, et al.Lancet (London, England)|September 10, 2016
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trialJ Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, et al.British Journal of Clinical Pharmacology|September 30, 2025
An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon-like peptide-1 and glucagon receptor in healthy subjectsJames Goodman, Victoria E Parker, Carmel M McEniery, et al.Translational Psychiatry|June 25, 2025
Elevated plasma GDF15 combined with FGF21 suggests mitochondrial dysfunction in a subgroup of anorexia nervosa patientsJingjing Xu, Ruyue Zhang, Vincent Millischer, et al.Brain Imaging and Behavior|August 26, 2015
Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV diseaseLindsay J Hines, Eric N Miller, Charles H Hinkin, et al.Nature Medicine|October 3, 2023
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trialLars Krogvold, Ida Maria Mynarek, Erica Ponzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III)Hans-Joachim Schmoll, David Cunningham, Alberto Sobrero, et al.Diabetic Medicine : a Journal of the British Diabetic Association|August 10, 2023
Diagnosis and treatment of anti-insulin antibody-mediated labile glycaemia in insulin-treated diabetesDavid S Church, Peter Barker, Keith A Burling, et al.Pageof 8